# IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS

> **NCT04848766** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 9000 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Coronary Artery Disease

## Interventions

- **DRUG:** De-escalation Treatment Strategy of dual antiplatelet therapy

## Key facts

- **NCT ID:** NCT04848766
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-07
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 9000 (ESTIMATED)
- **Last updated:** 2021-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04848766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04848766, "IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04848766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*